The newly identified miR-429-CRKL axis partially elucidates the molecular mechanism of HCC metastasis and represents a new potential therapeutic target for HCC treatment, miR-429 overexpression in combination with CRKL knockdown may be an effective strategy in reducing HCC metastasis. This evidence concerns the gene CRKL and hepatocellular carcinoma.